Three studies presented at SfN Neuroscience 2019 reveal advancements in autism research that could improve intervention and treatment.
Browsing: autism spectrum disorders
In the largest study of its kind, researchers discovered that testosterone does not impair cognitive empathy, challenging the notion of autism as reflecting an ‘extreme male brain’.
A recent study has determined a connection between reduced redundant synapses of autism spectrum disorder mouse brains and exercise. This could offer a possibility of reversing behavioral defects seen in autism spectrum disorder.
For the first time, researchers have revealed that autism could result from mutations in the noncoding regions of the human genome.
In this interview, we spoke with Alysson Muotri about defining cell maturity in brain organoids and how we could address the challenges with these systems.
Neonatologists have determined that there may be links between disruption of placental allopregnanolone delivery to the fetus and brain injuries associated with autism.
In the largest exome sequencing of autism spectrum disorder to date, researchers have identified 102 possible gene candidates.
A recent study has reported that defects in a nuclear receptor located in the brain could be linked to autism spectrum disorders.
Balovaptan, a molecule being developed by Roche for autism spectrum disorder, has been given FDA approval in order to accelerate its development.